Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India flag India · Delayed Price · Currency is INR
114.68
-0.76 (-0.66%)
At close: Apr 28, 2026
-4.43%
Market Cap 9.04B
Revenue (ttm) 612.17M
Net Income (ttm) 117.33M
Shares Out 78.84M
EPS (ttm) 2.03
PE Ratio 56.43
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 220,016
Average Volume 367,259
Open 114.98
Previous Close 115.44
Day's Range 113.70 - 116.60
52-Week Range 98.36 - 123.00
Beta n/a
RSI 63.45
Earnings Date Feb 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit... [Read more]

Industry Hospitals
Founded 2014
Employees 338
Stock Exchange National Stock Exchange of India
Ticker Symbol GKSL
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:GKSL's revenue was 402.42 million, an increase of 742.89% compared to the previous year's 47.74 million. Earnings were 94.13 million, an increase of 449.19%.

Financial Statements

News

There is no news available yet.